Piramal Pharma aims to double turnover to $2 billion by 2030

Q: How long will it take to read this news story?

The story "Piramal Pharma aims to double turnover to $2 billion by 2030" has 709 words across 26 sentences, which will take approximately 3 - 6 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Piramal Pharma aims to double turnover to $2 billion by 2030" was covered 1 days ago by Times of India, a news publisher based in India.

Q: How trustworthy is 'Times of India' news outlet?

Times of India is a fully independent (privately-owned) news outlet established in 1838 that covers mostly economy and business news. The outlet is headquartered in India and publishes an average of 23 news stories per day. It's most recent story was published 3 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #22710042</li><li>URL: https://beamstart.com/news/piramal-pharma-aims-to-double-17272932967034</li></ul>

Times of India 1d ago

Piramal Pharma aims to double turnover to $2 billion by 2030 - Times of India

Quick Summary:

Piramal Pharma plans to double its turnover to $2 billion by 2030, focusing on its CDMO business and high-growth sectors like complex hospital generics and consumer healthcare.

The company aims for significant revenue growth and improved EBITDA margins through strategic investments, expansions, and leveraging cost-efficient manufacturing infrastructure in India.

Elaborating on the CDMO segment which contributes a lion’s share, 58% to the total revenue, and is the fastest growing, she said it is well-positioned to service customers in “the East and West,” without the China option.